Updates are available Correction dated 2019-05-28
Click to view Correction: https://doi.org/10.1007/s10803-019-04076-z
-
Authors
Houghton, Richard http://orcid.org/0000-0003-3708-0393
Monz, Brigitta
Law, Kiely
Loss, Georg
Le Scouiller, Stephanie
de Vries, Frank
Willgoss, Tom
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Simons Foundation
Patient-Centered Outcomes Research Institute (PPRN-1501-26462)
- License Information
-
More Information
Article History
First Online: 9 April 2019
Change Date: 28 May 2019
Change Type: Correction
Change Details: The article Psychometric Validation of the Autism Impact Measure (AIM), written by Richard Houghton, Brigitta Monz, Kiely Law, Georg Loss, Stephanie Le Scouiller, Frank de Vries and Tom Willgoss was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 09 April 2019 without open access.With the author(s)’ decision to opt for Open Choice the copyright of the article changed on May 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Compliance with ethical standards
:
: RH, BM, GL, SLS and TW are full-time employees of F. Hoffmann-La Roche Ltd., which has drugs for autism under development. BM and TW holds stock options from F. Hoffmann-La Roche Ltd. KL is a research consultant with the Simons Foundation Autism Research Initiative which funds and operates SPARK. FV: none.
: Informed consent was obtained from all individual participants included in the study. The study protocol was approved by Western IRB.
